Process
1. Comprehensive Initial Consultation: Begin your journey with a thorough 30-45 minute session, whether in-person or virtual. During this consultation, we delve into your health history, recent lab results, dietary habits, and personal goals to devise a customized plan tailored to your needs.

2. Monthly Check-Ins: Monitor your progress and address any concerns with our 30-minute monthly sessions. These check-ins offer valuable opportunities to track your progress and refine your strategy for optimal results.

Pricing
Initial Consultation: $200
Includes comprehensive evaluation and nutritional counseling session.

• Monthly Cost: Typically ranges $349 - $849 depending on the medication and dosage prescribed (Wegovy or Zepbound).

• Monthly Process Order Fee: $35
  Includes your monthly check-in, prescription processing, and ongoing support.

Note:
The cost of medication will vary based on which medication and dose are ordered.
Payment for medication is processed directly through your local pharmacy (for Wegovy) or LillyDirect™ (for Zepbound).

Additional Benefits
• Exclusive Discounts: Receive discounts on IV treatments, Vitamin Injections, and Biostimulator treatments throughout your weight loss journey.
Treatment Overview

Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved injectable medications designed to support sustainable weight loss when used alongside a healthy diet and exercise plan.

• Wegovy works by mimicking the GLP-1 (glucagon-like peptide-1) hormone, which helps regulate appetite, increase fullness, and slow gastric emptying—leading to reduced calorie intake and improved weight management.

• Zepbound acts on both GLP-1 and GIP receptors, making it a dual-action medication. This helps control blood sugar levels, reduce appetite, and enhance satiety, offering a powerful approach for those struggling with obesity or weight-related conditions.

These medications are clinically proven to support meaningful and sustained weight loss for qualifying individuals.

When integrated into a comprehensive regimen of diet and exercise, Peptides demonstrate the potential for substantial weight reduction among individuals grappling with obesity or overweight conditions.

According to FDA guidelines, the administration of Peptides for weight loss is suggested under the following circumstances:

• Individuals with a body mass index (BMI) equal to or exceeding 27kg/m2, in conjunction with at least one weight-related ailment, such as hypertension, type 2 diabetes, or hypercholesterolemia.

• Individuals with a BMI of 30kg/m2 or higher.

Potential Side Effects or Complications
The side effects associated with Peptide Therapy Treatment are generally mild, particularly when contrasted with the complications linked to overweight and obesity.

While undergoing Peptide Therapy Treatment, individuals may encounter the following:

• Gastrointestinal symptoms: Nausea/vomiting, abdominal pain, diarrhea/constipation, dyspepsia, abdominal distension, eructation, flatulence, gastroenteritis, GERD (gastroesophageal reflux disease), gastritis, increased lipase, increased amylase.

• Neurological manifestations: Headache, dizziness.

• Cardiac implications: Increased heart rate, hypotension.

• Endocrine effects: Fatigue, hypoglycemia (in diabetic patients), alopecia.

• Ophthalmic concerns: Retinal disorders (in diabetic patients).

• Dermatological reactions: Redness or pain at the injection site